Pharmacoeconomic Effectiveness of the Inclusion of Glycopyrronium Bromide into the Program of Reimbursement of Essential Drugs for Patients with COPD
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1527
https://www.valueinhealthjournal.com/article/S1098-3015(17)31861-2/fulltext
Title :
Pharmacoeconomic Effectiveness of the Inclusion of Glycopyrronium Bromide into the Program of Reimbursement of Essential Drugs for Patients with COPD
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31861-2&doi=10.1016/j.jval.2017.08.1527
First page :
A652
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1376